Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiplexed testing in the autoimmunity laboratory.

José M González-Buitrago1

  • 1Laboratorio de Autoinmunidad, Servicio de Bioquímica Clínica, Hospital Universitario de Salamanca, y Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Salamanca, Spain. buitrago@usal.es

Clinical Chemistry and Laboratory Medicine
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary TCP1-eta: A Cortical Damage Marker for the Pathophysiological Diagnosis and Prognosis of Acute Kidney Injury.

Toxicological sciences : an official journal of the Society of Toxicology·2019
Same author

Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: role of the Akt/mTOR survival pathway and Bcl-2 family proteins.

Free radical biology & medicine·2013
Same author

Functional specific roles of H-ras and N-ras. A proteomic approach using knockout cell lines.

Electrophoresis·2012
Same author

Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.

Clinica chimica acta; international journal of clinical chemistry·2012
Same author

Urinary levels of regenerating islet-derived protein III β and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats.

Kidney international·2010
Same author

Sub-nephrotoxic doses of gentamicin predispose animals to developing acute kidney injury and to excrete ganglioside M2 activator protein.

Kidney international·2010

Multiplexed autoantibody profiling technologies offer faster autoimmune disease diagnosis. Bead-based assays and line-blot immunoassays are commercialized, with antigen microarrays in development for broader autoantibody detection.

Area of Science:

  • Clinical immunology
  • Biotechnology
  • Diagnostic assay development

Background:

  • Autoantibody profiling is crucial for diagnosing autoimmune diseases.
  • Current methods vary in the number of autoantibodies they can detect.
  • Multiplexed testing offers potential for improved efficiency.

Purpose of the Study:

  • To review existing and emerging technologies for autoantibody profiling.
  • To assess the capabilities and commercialization status of different assay types.
  • To highlight the future potential of multiplexed testing in autoimmunity laboratories.

Main Methods:

  • Review of current autoantibody profiling technologies.
  • Comparison of line-blot immunoassays, bar-coded nanoparticle immunoassays, bead-based assays with flow cytometry, and antigen microarrays.

Related Experiment Videos

  • Analysis of assay multiplexing capabilities and commercial availability.

    • Main Results:

    • Several technologies for autoantibody profiling exist, including line-blot immunoassays, bar-coded nanoparticle immunoassays, bead-based assays with flow cytometry, and antigen microarrays.
    • Line-blot immunoassays and bead-based assays for antinuclear antibody specificities are commercialized.
    • Antigen microarrays are in development but expected to reach the market soon.

    Conclusions:

    • Multiplexed autoantibody testing is a promising advancement for autoimmunity laboratories.
    • These technologies can significantly reduce analytical time and improve turnaround time for diagnoses.
    • The development of antigen microarrays will further expand autoantibody detection capabilities.